.png){kind=logo}
Meet #MiniMedChampion Jason
Jason Ziobrowski, also known as Chef Jay Z, is on a mission to influence others positively through food. Diagnosed with type 1 diabetes in his early forties, his journey has been one of transformation and resilience, as he now works as a corporate R&D chef for a leading national food and nutrition services company dedicated to serving 900+ hospitals and healthcare systems.
Transitioning to the MiniMed 780G system
While Jason was initially skeptical about using an insulin pump, his perspective changed after meeting another person living with type 1 diabetes who was using the MiniMed 780G pump herself. “Meeting her, and her convincing me what to do and how easy it was, really encouraged me to say, ‘All right, let’s do this,’” says Jason, who transitioned to the MiniMed 780G system in 2024.
The system has significantly improved his life by helping stabilize glucose levels.† experiences less extreme fluctuations in blood sugar levels that he did before using the pump. “I believe the insulin pump, and the support system I have in place, have [made my life better],” he says.
Promoting healthy eating
Jason has a passion for educating people about healthy eating and is on a personal mission to change the American palate, one mouth at a time. Today, he develops recipes for hospital cafes and patients, conducts training sessions, and creates educational content to promote better dietary habits. His inspiring story of lowering his A1C levels and maintaining his health for over a decade through food as medicine is a testament to the power diet can play when it comes to managing chronic conditions. His efforts to educate people about the impact of diet on health and his dedication to creating nutritious meals for hospital settings are helping make a positive difference in the lives of many.
Footnote
† Refers to SmartGuard™ feature. Individual results may vary.
Important Safety Information: MiniMedTM 780G system with SmartGuardTM technology with Instinct sensor, Simplera SyncTM sensor, and GuardianTM 4 sensor
The MiniMedTM 780G system is intended for the continuous delivery of basal insulin at selectable rates and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose vales in the fluid under the skin.
The MiniMedTM 780G System includes SmartGuardTM technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera SyncTM and GuardianTM 4 sensors and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.
WARNING: Do not use the SmartGuardTM feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuardTM feature.
WARNING: Do not use MiniMedTM 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of MiniMedTM 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuardTM feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including accessories and additional important safety information concerning indications, contraindications, warnings and precautions associated with the system and its components, please consult https://www.minimed.com/important-safety-information and the appropriate user guide at https://www.minimed.com/support/download-library.
©2026 MiniMed. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2026 Abbott. TM*Third–party brands are trademarks of their respective owners.
DreaMed Diabetes is a trademark of DreaMed Diabetes, Ltd. The MiniMedTM 780G system algorithm includes technology developed by DreaMed Diabetes.